Large drugmakers with the fastest earnings growth
Earnings per share over the last twelve months against the twelve months before, for companies profitable in both. As of .
- Ranked
- 24
- of 411 large drugmakers we cover
- Median
- −8.3%
- Highest
- +250.0%
- INDV
- Range
- −89.0% to +250.0%
median −8.3%
−89.0%+250.0%
Not ranked: 295 with not a meaningful number, 19 with a quarter missing, 15 with no profit to compare, 6 with growth above 300% (a base too small to compare). 52 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
EPS growth for other groups
Other rankings of large drugmakers
- Large drugmakers with the lowest PE ratio
- Large drugmakers cheapest against their own PE history
- Large drugmakers with the lowest price to sales ratio
- Large drugmakers with the lowest EV/EBIT
- Large drugmakers with the highest free cash flow yield
- Large drugmakers with the fastest revenue growth
- Large drugmakers with the highest profit margins